June 13, 2020 / 5:58 PM / 21 days ago

BRIEF-Sinovac Says Positive Prelim Results Of Phase I/II Trials For COVID-19 Vaccine Candidate

June 13 (Reuters) - Sinovac Biotech Ltd:

* SINOVAC ANNOUNCES POSITIVE PRELIMINARY RESULTS OF PHASE I/II CLINICAL TRIALS FOR INACTIVATED VACCINE CANDIDATE AGAINST COVID-19

* THERE HAVE BEEN NO SEVERE ADVERSE EVENT REPORTED IN EITHER PHASE I OR PHASE II TRIALS

* SINOVAC BIOTECH - EXPECTS TO SUBMIT A PHASE II CLINICAL STUDY REPORT AND A PHASE III CLINICAL STUDY PROTOCOL TO CHINA’S NMPA IN NEAR FUTURE

* SINOVAC BIOTECH - COMPANY’S COVID-19 VACCINE CANDIDATE, CORONAVAC, SHOWED FAVORABLE IMMUNOGENICITY AND SAFETY PROFILES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below